Citizens analyst Aaron Kimson lowered the firm’s price target on Blend Labs (BLND) to $5 from $7 and keeps an Outperform rating on the shares. The company reported “strong” Q4 results but its Q1 guidance is “disappointing,” the analyst tells investors in a research note. Citizens reduced estimates but says the financial institution customers Blend serves will want to stay in the mortgage business.
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
